Which vaccines will RFK end recommendations for?
Which vaccines will RFK end recommendations for?
$1,399,277 交易量
2025-12-31
Polio
No
COVID-19
No
HPV
No
Influenza
No
Hepatitis B
No
Measles Mumps and Rubella
No
$1,399,277 交易量
Polio
$22,600 交易量
No
COVID-19
$602,048 交易量
No
HPV
$316,492 交易量
No
Influenza
$28,349 交易量
No
Hepatitis B
$166,216 交易量
No
Measles Mumps and Rubella
$263,573 交易量
No
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
市場開放時間: Feb 21, 2025, 7:10 PM ET
交易量
$1,399,277結束日期
2025-12-31市場開放時間
Feb 21, 2025, 7:10 PM ETResolver
0x6A9D22261...已提議結果: No
無爭議
最終結果: No
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.
The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
交易量
$1,399,277結束日期
2025-12-31市場開放時間
Feb 21, 2025, 7:10 PM ETResolver
0x6A9D22261...已提議結果: No
無爭議
最終結果: No

警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions